Riverview Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-268
Closed -$21.5K 435
2025
Q1
$21.5K Sell
268
-15
-5% -$1.25K 0.02% 400
2024
Q4
$23.2K Hold
283
0.02% 408
2024
Q3
$23.3K Buy
283
+15
+6% +$1.12K 0.02% 398
2024
Q2
$18.8K Hold
268
0.02% 463
2024
Q1
$19.9K Buy
+268
New +$18.7K 0.02% 486
2023
Q4
Sell
-268
Closed -$16.9K 422
2023
Q3
$16.9K Hold
268
0.01% 455
2023
Q2
$15.2K Sell
268
-820
-75% -$45.5K 0.01% 514
2023
Q1
$63K Hold
1,088
0.06% 178
2022
Q4
$79K Buy
1,088
+886
+439% +$63.5K 0.07% 160
2022
Q3
$12K Sell
202
-480
-70% -$30.7K 0.01% 604
2022
Q2
$43K Buy
682
+171
+33% +$11.3K 0.04% 232
2022
Q1
$36K Buy
+511
New +$34.5K 0.03% 266
2019
Q2
Sell
-97
Closed -$4K 355
2019
Q1
$4K Buy
+97
New +$4.29K ﹤0.01% 306

Other funds holding MET

Riverview Trust Company's MET Position: Q2 2025 in Review

Riverview Trust Company sold out of MetLife (MET) in Q2 2025, closing a stake of 268 shares — an estimated $21.5K sold.

Riverview Trust Company first reported a position in MET in Q1 2019 and held it in 13 quarters. The position peaked at $79K in Q4 2022. 1,411 funds tracked by Wall St. Rank hold MET as of Q2 2025.

  • Riverview Trust Company reported no remaining MetLife position as of Q2 2025 after selling out during the quarter.
  • Riverview Trust Company sold 268 MetLife shares in Q2 2025, an estimated $21.5K.
  • Riverview Trust Company first reported a position in MetLife in Q1 2019 and held it in 13 quarters.
  • Riverview Trust Company's MetLife position peaked at $79K in Q4 2022.
  • 1,411 funds tracked by Wall St. Rank held MetLife as of Q2 2025.

Based on Riverview Trust Company's 13F filing for Q2 2025, filed 21 Jul 2025.